Alcon Inc. (ALC.SW) Financials
ALC.SW Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
March 31, 2025 | 27.3 billion | 7.9 billion |
Dec. 31, 2024 | 27.4 billion | 8.0 billion |
Sept. 30, 2024 | ? | ? |
June 30, 2024 | 26.8 billion | 7.9 billion |
ALC.SW Free Cash Flow and Stock based compensation
Date | Free Cash Flow | Stock based compensation |
---|---|---|
March 31, 2025 | 338.5 million | ? |
Dec. 31, 2024 | ? | ? |
Sept. 30, 2024 | ? | ? |
June 30, 2024 | 369.2 million | 30.6 million |
ALC.SW Net Income
Date | Net Income |
---|---|
March 31, 2025 | 308.5 million |
Dec. 31, 2024 | 256.8 million |
Sept. 30, 2024 | 222.3 million |
June 30, 2024 | 200.8 million |
ALC.SW Cash and Debt
Date | Cash | Debt | Capital Lease |
---|---|---|---|
March 31, 2025 | 1.2 billion | 4.4 billion | 441.6 million |
Dec. 31, 2024 | 1.7 billion | 4.5 billion | 449.4 million |
Sept. 30, 2024 | 1.3 billion | - | - |
June 30, 2024 | 1.2 billion | 4.4 billion | 362.9 million |
ALC.SW Shares Outstanding
ALC.SW Expenses
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
March 31, 2025 | - | 195.7 million | 716.6 million | - |
Dec. 31, 2024 | - | 232.0 million | 802.0 million | - |
Sept. 30, 2024 | - | 190.2 million | 683.9 million | - |
June 30, 2024 | 108.0 million | 198.1 million | 753.6 million | - |
ALC.SW Cost of Revenue
Date | Revenue | Cost of Revenue |
---|---|---|
March 31, 2025 | 2.2 billion | 960.7 million |
Dec. 31, 2024 | 2.5 billion | 1.1 billion |
Sept. 30, 2024 | 2.1 billion | 915.5 million |
June 30, 2024 | 2.2 billion | 1.0 billion |
ALC.SW
Price: CHF69.80
Dividend Yield: 0.37%
Forward Dividend Yield: 0.40%
Payout Ratio: 12.77%
Dividend Per Share: 0.28 CHF
Earnings Per Share: 1.87 CHF
P/E Ratio: 37.56
Exchange: EBS
Sector: Healthcare
Industry: Medical Instruments & Supplies
Market Capitalization: 34.7 billion
Average Dividend Frequency: 1
Years Paying Dividends: 6
DGR3: 30.00%